CAR T cell News and Research

RSS
New light-activated technology enhances immune cells' ability to target solid tumors

New light-activated technology enhances immune cells' ability to target solid tumors

UCLA and Parker Institute renew alliance to advance cancer immunotherapy

UCLA and Parker Institute renew alliance to advance cancer immunotherapy

Outpatient CAR-T therapy shows promise for treating lymphoma patients

Outpatient CAR-T therapy shows promise for treating lymphoma patients

Study shows CAR T-cell therapy's risk of second primary malignancies comparable to other treatments

Study shows CAR T-cell therapy's risk of second primary malignancies comparable to other treatments

Cancer drug offers life-changing results for severe lupus patient

Cancer drug offers life-changing results for severe lupus patient

Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma

Overcoming cancer relapse with CAR-Enhancer therapy

Overcoming cancer relapse with CAR-Enhancer therapy

Study highlights infection as major post-CAR-T therapy challenge

Study highlights infection as major post-CAR-T therapy challenge

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

Stem-like cells found to drive growth of aggressive pediatric brain tumors

Stem-like cells found to drive growth of aggressive pediatric brain tumors

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

Transforming growth factor beta inhibition boosts NK cell therapy against hepatocellular carcinoma

New hope for solid tumors with enhanced CAR-T cells

New hope for solid tumors with enhanced CAR-T cells

Early detection of aggressive multiple myeloma through molecular analysis

Early detection of aggressive multiple myeloma through molecular analysis

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Case study sheds light on CAR-T therapy-related secondary cancers

Case study sheds light on CAR-T therapy-related secondary cancers

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

UC San Diego Health launches personalized immunotherapy for metastatic melanoma

Single infusion of engineered T-cells achieves lasting asthma remission in mice

Single infusion of engineered T-cells achieves lasting asthma remission in mice

Evolving treatment paradigms in multiple myeloma could improve patient outcomes

Evolving treatment paradigms in multiple myeloma could improve patient outcomes

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

MRI and lumbar puncture may not be necessary for managing CAR T-cell associated toxicities

MRI and lumbar puncture may not be necessary for managing CAR T-cell associated toxicities

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.